Rifakem And Esokem Drug Quiz!

20 Questions | Total Attempts: 550

SettingsSettingsSettings
Rifakem And Esokem Drug Quiz! - Quiz

.


Questions and Answers
  • 1. 
    The punch line of Esokem is
    • A. 

      An Ideal PPI for your Rx

    • B. 

      An Ideal PPI that completes your Rx

    • C. 

      A PPI for Superior Acid Control

    • D. 

      Choose an Ideal PPI

  • 2. 
    Esokem offers intragastric pH above 4, how many hours more than other PPI.
    • A. 

      8

    • B. 

      7

    • C. 

      6

    • D. 

      5

  • 3. 
    Eskom maintains intragastric pH above 4 for
    • A. 

      11 hrs

    • B. 

      16.8 hrs

    • C. 

      15 hrs

    • D. 

      20 hrs

  • 4. 
    Which statement is true:
    • A. 

      Rifakem only acts as Bacteriostatic

    • B. 

      Rifakem only acts as Bactericidal

    • C. 

      Rifakem is both Bacteriostatic & Bactericidal

    • D. 

      None of the above

  • 5. 
    Esokem offers, how much % higher bioavailability compared to other PPI.
    • A. 

      11% to 22%

    • B. 

      11% to 44%

    • C. 

      5% to 10%

    • D. 

      8% to 16%

  • 6. 
    Esokem offers, how much %  higher healing rate compared to other PPI.
    • A. 

      2% to 4%

    • B. 

      4% to 6%

    • C. 

      20% to 30%

    • D. 

      8% to 16%

  • 7. 
    Domperidone in Esokem-D offers:
    • A. 

      Superior prokinetic action

    • B. 

      No action on gut motility, but inhibits nausea & vomiting

    • C. 

      Single mode of action with no side effect

    • D. 

      Non prokinetic action, but inhibits nausea & vomiting

  • 8. 
    Esokem 20 is
    • A. 

      Tablet

    • B. 

      Capsule

  • 9. 
    Esokem-D is available in:
    • A. 

      Tablet

    • B. 

      Capsule

  • 10. 
    The puch line of Rifakem is:
    • A. 

      The Gut Modulator

    • B. 

      The Gut Microbiots

    • C. 

      The Gut Microbiota Modulator

    • D. 

      The Gut Cytoprotector

  • 11. 
    Rifakem offers Modulation of Gut-immune signalling, thus works in indications of:
    • A. 

      Cirrhosis related Bacterial Complication

    • B. 

      IBS-D & Crohn’s disease

    • C. 

      Infectious Diarrhoea

    • D. 

      HE

  • 12. 
    Rifakem improves IBS symptom:
    • A. 

      Up to 15 weeks after discontinuation of therapy

    • B. 

      Up to 10 weeks during continuation of therapy

    • C. 

      Up to 10 weeks after discontinuation of therapy

    • D. 

      Up to 20 weeks after discontinuation of therapy

  • 13. 
    Rifakem offers:
    • A. 

      Lower Glucose Breath normalization rate & decontamination rate

    • B. 

      Higher Glucose Breath normalization rate & contamination rate

    • C. 

      Higher Glucose Breath normalization rate & decontamination rate

    • D. 

      Lower Glucose Breath normalization rate & contamination rate

  • 14. 
    Rifakem can only be administered after food.
    • A. 

      True

    • B. 

      False

  • 15. 
    Rifakem is not GI specific.
    • A. 

      True

    • B. 

      False

  • 16. 
    Which among the following is correct for Rifakem:
    • A. 

      Non-aminoglycoside semi-synthetic, systemic antibiotic

    • B. 

      Aminoglycoside semi-synthetic, non-systemic antibiotic

    • C. 

      Non-aminoglycoside natural, systemic antibiotic

    • D. 

      Non-aminoglycoside semi-synthetic, non-systemic antibiotic

  • 17. 
    Rifaximin acts by binding to the beta sub-unit of bacterial DNA dependent RNA polymerase resulting in …………………………………..
    • A. 

      Inhibition of bacterial DNA synthesis

    • B. 

      Inhibition of bacterial RNA synthesis

  • 18. 
    Rifakem causes AAD.
    • A. 

      True

    • B. 

      False

  • 19. 
    Most of the Gut pathogenic bacteria are resistance to Rifakem.
    • A. 

      True

    • B. 

      False

Back to Top Back to top